Effect of treatment with L-Carnitin versus no treatment on the stage of disease in patients with nonalcoholic fatty liver
Phase 2
Completed
- Conditions
- nonalcoholic fatty liver.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT201610069014N121
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Affected with nonalcoholic fatty liver.
Exclusion criteria: Using methotrexate medication; viral hepatitis; hyperthyroidisms; hypothyroidisms; uncontrolled diabetes.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the stage of disease. Timepoint: before and 6 months after treatment. Method of measurement: using liver sonography.
- Secondary Outcome Measures
Name Time Method Assessing liver enzymes. Timepoint: before and 6 months after treatment. Method of measurement: using laboratory tests.